• USA

Risk Reduction Solutions for
Pharmaceutical, Life Sciences & Healthcare

  • USA
  • Resources
    • FAQs
    • Quality Certificates
    • Studies & Publications
    • Bioquell QuAD Data Portal
    • Material Safety Data Sheets
  • News & Events
  • Company
    • About Us
    • Company Locations
    • Distributors
    • Careers
    • Ecolab Life Sciences
  • Pharmaceuticals & Life Sciences
    • Our Technology for Life Sciences
    • Why Bioquell Technology?
    • Systems for Life Sciences
    • Rapid Bio Decontamination Service
    • Validation
    • Consumables & Related Accessories
    • Ecolab Life Sciences
  • Healthcare
    • Why Bioquell Technology?
    • The Bioquell Process
    • Bioquell Compared to UV
    • Vaporized vs Aerosolized
    • Systems for Healthcare
    • Services for Healthcare
    • Consumables & Related Accessories
  • EMS
  • Rapid Bio Decontamination Service
    • For Life Sciences
    • For Healthcare
    • Business Continuity
    • Applications
      • Remediation Needs
      • Emergency Response
      • Disaster Recovery Plan
      • Commissioning
      • End of Campaign and Facility Restart
      • Lab and Research Spaces
      • Hospital Related Contamination Events
  • Qube Isolator
    • About the Bioquell Qube
    • For Sterility Testing
  • Contact
notification

Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.

Click here for more information. 

x
    • Pharmaceuticals & Life Sciences
      • Our Technology for Life Sciences
      • Why Bioquell Technology?
      • Systems for Life Sciences
      • Rapid Bio Decontamination Service
      • Validation
      • Consumables & Related Accessories
      • Ecolab Life Sciences
    • Healthcare
      • Why Bioquell Technology?
      • The Bioquell Process
      • Bioquell Compared to UV
      • Vaporized vs Aerosolized
      • Systems for Healthcare
      • Services for Healthcare
      • Consumables & Related Accessories
    • EMS
    • Rapid Bio Decontamination Service
      • For Life Sciences
      • For Healthcare
      • Business Continuity
      • Applications
        • Remediation Needs
        • Emergency Response
        • Disaster Recovery Plan
        • Commissioning
        • End of Campaign and Facility Restart
        • Lab and Research Spaces
        • Hospital Related Contamination Events
    • Qube Isolator
      • About the Bioquell Qube
      • For Sterility Testing
    • Contact

Bioquell PLC

Bioquell Plc (“Bioquell”) was acquired by Ecolab Inc with effect from 16 January 2019 by means of a Court sanctioned Scheme of Arrangement at 590 pence per share.

The latest date for the dispatch of cheques to Scheme Shareholders and settlement through CREST is 30 January 2019.

Dealings in Bioquell Shares were suspended with effect from 6.00 p.m. (London time) on 15 January 2019. Applications have been made to the UK Listing Authority and the London Stock Exchange in relation to the delisting of Bioquell Shares from the Official List of the UK Listing Authority and the cancellation of the admission to trading of Bioquell Shares on the Main Market for listed securities of the London Stock Exchange, which are each expected to take effect from 8.00 a.m. (London time) on 17 January 2019.

Any shareholders in Bioquell PLC who wish to make contact with the Company regarding their shareholding should in the first instance contact the Company Secretary, Georgina Pope, by email: georgina.pope@bioquell.com

Sales and Technical Support & General Inquiries: +1 215 682 0225

702 Electronic Drive, Suite 200, Horsham, PA 19044

bioquellusorders@ecolab.com

  • © Bioquell, An Ecolab Solution 2025 All Rights Reserved
  • Privacy Policy
  • Terms of Use
Download PDF